Abstract
Objective: The present study was aimed to develop a rapid, accurate, linear, sensitive and validate stability-indicating high performance liquid chromatographic [RP-HPLC] method for determination of vildagliptin and metformin in pharmaceutical dosage form.Methods: The chromatographic separation was performed on kromasil-C18 column [4.5 x 250 mm; 5 µm] using a mobile phase consisting of 0.05 mmol potassium dihydrogen phosphate buffer: acetonitrile [80:20 v/v], [pH adjusted to 3.5 using orthophosphoric acid]. The flow rate is 0.9 ml/min and the detection was carried out at 263 nm.Results: The chromatographic condition, the peak retention time of metformin and vildagliptin were found to be 2.215 min and 2.600 min respectively. Stress testing was performed in accordance with an international conference on harmonization [ICH] Q1A R2 guidelines. The method was validated as per ICH Q2 R1 guidelines. The calibration curve was found to be linear in the concentration range of 5-17.5 µg/ml and 50-175 µg/ml for vildagliptin and metformin. The limit of detection and quantification was found to be 0.0182 µg/ml and 0.0553 µg/ml for vildagliptin and 0.4451 µg/ml and 1.3490 µg/ml for metformin respectively.Conclusion: A new sensitive, simple and stability indicating reverse-phase high-performance liquid chromatography [RP-HPLC] method has been developed and validated for the determination of vildagliptin and metformin. The proposed method can be used for routine determination of vildagliptin and metformin.
Highlights
Vildagliptin [fig. 1] is chemically [S]-1-[N-[3-hydroxy-1-adamantyl] glycyl] pyrrolidine-2-carbonitrile, is a potent di-peptidyl peptidase IV [dip-IV] inhibitor, a drug for the treatment of diabetes
Metformin HCl [fig. 2] chemically 3-[diaminomethylidene]-1,1dimethylguanidine HCl is an orally administered biguanide widely used in the treatment of type 2 [non-insulin dependent] diabetes mellitus [5,6]
The method development for analysis of vildagliptin and metformin Hcl was performed using various solvents the separation was achieved using a mobile phase consisting of 0.05 mmol potassium dihydrogen phosphate buffer: acetonitrile [80:20 v/v], pH adjusted to 3.5 using orthophosphoric acid, pumped at a flow rate of 0.9 ml/min
Summary
Vildagliptin [fig. 1] is chemically [S]-1-[N-[3-hydroxy-1-adamantyl] glycyl] pyrrolidine-2-carbonitrile, is a potent di-peptidyl peptidase IV [dip-IV] inhibitor, a drug for the treatment of diabetes. 1] is chemically [S]-1-[N-[3-hydroxy-1-adamantyl] glycyl] pyrrolidine-2-carbonitrile, is a potent di-peptidyl peptidase IV [dip-IV] inhibitor, a drug for the treatment of diabetes. DPP-IV inhibitor represents a new class of oral antihyperglycemic agents to treat patients with type 2 diabetes [1,2,3,4]. 2] chemically 3-[diaminomethylidene]-1,1dimethylguanidine HCl is an orally administered biguanide widely used in the treatment of type 2 [non-insulin dependent] diabetes mellitus [5,6]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
